The recent recall of over 580,000 bottles of prazosin hydrochloride, a commonly prescribed medication for high blood pressure, has raised important questions about medication safety. In October 2025, Teva Pharmaceuticals initiated a voluntary recall after testing detected elevated levels of nitrosamine impurities—compounds classified as potential carcinogens with long-term exposure. This Class II recall, as classified by the FDA, highlights ongoing concerns in generic drug manufacturing, but it does not mean all blood pressure medications are affected or that immediate danger exists for most users.
Many people managing hypertension feel uneasy when hearing about such recalls, especially when the word “cancer” appears in headlines. The worry is understandable—relying on daily medication for heart health already involves trust in the supply chain, and news like this can shake that confidence. Studies and regulatory bodies like the FDA continue to monitor these impurities closely because even low levels over extended periods warrant attention.
The good news is that regulatory systems exist to catch and address these issues quickly, and alternatives are usually available. In this article, we’ll break down what happened with the prazosin recall, explain nitrosamine impurities in simple terms, share steps you can take if you’re affected, and offer practical ways to support blood pressure management safely while staying informed.
What Exactly Happened in the Recent Prazosin Recall?
In early October 2025, Teva Pharmaceuticals USA announced a voluntary nationwide recall of more than 580,000 bottles of prazosin hydrochloride capsules in 1 mg, 2 mg, and 5 mg strengths. The recall also involved some lots distributed by Amerisource Health Services.
The reason? Laboratory testing found levels of a specific nitrosamine impurity (N-nitroso prazosin impurity C) above the FDA’s acceptable intake limits. Nitrosamines are a class of chemicals that can form during manufacturing or storage processes in certain drugs. While they occur naturally in some foods and the environment in trace amounts, higher levels in medications prompt action due to potential long-term risks.
The FDA classified this as a Class II recall, meaning use of the affected product may cause temporary or medically reversible adverse health effects, or the probability of serious effects is remote. This is not a Class I recall (high immediate risk), so the focus is on caution rather than emergency removal.
Prazosin, an alpha-blocker, helps relax blood vessels to lower blood pressure and is also used off-label for conditions like PTSD-related nightmares. Around 510,000 patients receive prescriptions for it annually in the U.S., making this a notable but targeted issue.
But that’s not the full picture—similar nitrosamine concerns have appeared in other blood pressure drugs over the years…
Understanding Nitrosamine Impurities: Why Do They Show Up?
Nitrosamines, such as NDMA or NDEA, have been a recurring topic in drug safety since major recalls of valsartan, losartan, and irbesartan starting in 2018. These impurities can develop from changes in manufacturing processes, certain solvents, or even storage conditions.
Research shows that nitrosamines are probable human carcinogens based on animal studies, but the actual risk from low-level exposure in medications is considered very low for short-term use. The FDA sets strict acceptable daily intake limits (for example, around 96 ng/day for NDMA in many cases) to keep lifetime cancer risk minimal—roughly equivalent to 1 in 100,000 over decades.
The prazosin case involved a specific impurity tied to the drug’s structure, highlighting why ongoing testing is crucial for generics, which make up most prescriptions today.
Here’s a quick comparison of recent blood pressure medication recalls involving nitrosamines:
- Prazosin (2025, Teva): Over 580,000 bottles; specific N-nitroso impurity; Class II.
- Valsartan/Losartan/Irbesartan (2018–2019): Multiple manufacturers; NDMA/NDEA/NMBA; widespread but resolved with new processes.
- Other recent examples: Some beta-blocker or combination pills recalled for unrelated contamination (e.g., cross-contamination with other drugs), not nitrosamines.
The key takeaway? These events drive improvements in manufacturing standards.
What Should You Do If You Take Prazosin or a Similar Medication?
Don’t stop taking your blood pressure medication without guidance—sudden changes can spike blood pressure and increase risks like stroke or heart issues. Here’s a step-by-step guide:
- Check your bottle: Look at the label for manufacturer (Teva or Amerisource), strength (1 mg, 2 mg, or 5 mg), and lot numbers. Compare against the FDA’s recall list (search “prazosin recall” on fda.gov for the latest enforcement report).
- Contact your pharmacy: They can verify if your supply is affected and provide replacements from unaffected lots or alternative medications.
- Talk to your doctor: Discuss switching to another alpha-blocker (like doxazosin) or a different class (e.g., ACE inhibitors, calcium channel blockers) if needed. They know your full health picture.
- Monitor your blood pressure: Use a home monitor regularly and log readings to share with your healthcare provider.
- Stay updated: Sign up for FDA alerts or check reliable sources like fda.gov/drug-recalls.
Many patients in similar situations have successfully transitioned to safe alternatives without disruption.
Everyday Habits to Support Healthy Blood Pressure (Beyond Medication)
While medication plays a key role, lifestyle supports better control and overall heart health. Research consistently shows these habits can help:
- Follow the DASH eating pattern: Emphasize fruits, vegetables, whole grains, lean proteins, and low-fat dairy while reducing sodium.
- Aim for movement: 150 minutes of moderate activity weekly, like brisk walking, can lower systolic pressure by 5–8 mmHg.
- Manage stress: Techniques like deep breathing or short meditation sessions reduce tension that affects blood vessels.
- Limit alcohol and quit smoking: Both directly impact vessel health.
- Maintain a healthy weight: Even modest loss improves readings.
Here’s a simple daily checklist to build these habits:
- Drink water instead of sugary drinks.
- Add one extra vegetable serving per meal.
- Take a 10–15 minute walk after dinner.
- Practice 5 minutes of mindful breathing before bed.
- Track sodium intake (aim under 2,300 mg/day, ideally 1,500 mg for hypertension).
These small steps compound over time and empower you to feel more in control.
Why Staying Informed Matters for Your Health Journey
Recalls like this one remind us that drug safety is an evolving process. The FDA and manufacturers work diligently to test and refine production, ensuring medications remain as safe as possible. If you’re concerned about your current prescription, reaching out to your healthcare team is the best next step—they can provide personalized reassurance or adjustments.
This recall affects specific lots only, and most blood pressure medications continue to be safe and effective when properly manufactured.
Frequently Asked Questions
Is prazosin the only blood pressure drug affected by nitrosamine issues recently? No, past recalls involved ARBs like valsartan and losartan, but current supplies have updated manufacturing to minimize impurities. The prazosin recall is specific and limited.
How do I know if my medication is safe? Check the FDA recall database or ask your pharmacist. They have access to the latest lot information.
Should I be worried about cancer risk from my blood pressure pills? The levels prompting recalls are low, and short-term exposure poses minimal risk per FDA assessments. Always consult your doctor for peace of mind rather than stopping meds abruptly.
Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making any changes to your medication or treatment plan. Information is based on publicly available FDA reports and general health guidelines as of early 2026.
